Optimum Communications, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Optimum Communications, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.59B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $8.95B | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $2.23B | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $2.24B | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $2.25B | May 2, 2024 |
| FY2025 | Dec 31, 2023 | $9.24B | Feb 13, 2026 |
| FY2024 | Sep 30, 2023 | $2.32B | Nov 5, 2024 |
| FY2024 | Jun 30, 2023 | $2.32B | Aug 1, 2024 |
| FY2024 | Mar 31, 2023 | $2.29B | May 2, 2024 |
| FY2024 | Dec 31, 2022 | $9.65B | Feb 13, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.87B) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($102.92M) | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | ($42.97M) | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $15.36M | Nov 5, 2024 |
| FY2024 | Mar 31, 2024 | ($21.19M) | Nov 5, 2024 |
| FY2025 | Dec 31, 2023 | $53.20M | Feb 13, 2026 |
| FY2024 | Sep 30, 2023 | $66.84M | Nov 5, 2024 |
| FY2024 | Jun 30, 2023 | $78.30M | Nov 5, 2024 |
| FY2024 | Mar 31, 2023 | $25.87M | Nov 5, 2024 |
| FY2024 | Dec 31, 2022 | $194.56M | Feb 13, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($112.56M) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.68B | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $444.59M | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $501.58M | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $393.15M | May 2, 2024 |
| FY2025 | Dec 31, 2023 | $1.70B | Feb 13, 2026 |
| FY2024 | Sep 30, 2023 | $492.57M | Nov 5, 2024 |
| FY2024 | Jun 30, 2023 | $481.98M | Aug 1, 2024 |
| FY2024 | Mar 31, 2023 | $425.13M | May 2, 2024 |
| FY2024 | Dec 31, 2022 | $1.80B | Feb 13, 2025 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $33.43M | Aug 1, 2024 |
| FY2023 | Dec 31, 2022 | $22.29M | Aug 1, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.58B | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $1.14B | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $706.46M | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $399.66M | May 2, 2024 |
| FY2025 | Dec 31, 2023 | $1.83B | Feb 13, 2026 |
| FY2024 | Sep 30, 2023 | $1.33B | Nov 5, 2024 |
| FY2024 | Jun 30, 2023 | $855.69M | Aug 1, 2024 |
| FY2024 | Mar 31, 2023 | $416.85M | May 2, 2024 |
| FY2024 | Dec 31, 2022 | $2.37B | Feb 13, 2025 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.35B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.43B | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $1.04B | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $683.82M | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $336.10M | May 2, 2024 |
| FY2025 | Dec 31, 2023 | $1.70B | Feb 13, 2026 |
| FY2024 | Sep 30, 2023 | $1.41B | Nov 5, 2024 |
| FY2024 | Jun 30, 2023 | $1.06B | Aug 1, 2024 |
| FY2024 | Mar 31, 2023 | $582.90M | May 2, 2024 |
| FY2024 | Dec 31, 2022 | $1.91B | Feb 13, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.70B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $31.70B | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $31.83B | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $32.02B | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $31.95B | May 2, 2024 |
| FY2024 | Dec 31, 2023 | $31.92B | Feb 13, 2025 |
| FY2023 | Sep 30, 2023 | $32.21B | Nov 1, 2023 |
| FY2023 | Jun 30, 2023 | $32.11B | Aug 3, 2023 |
| FY2023 | Mar 31, 2023 | $31.99B | May 3, 2023 |
| FY2023 | Dec 31, 2022 | $33.66B | Aug 1, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.00B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $32.16B | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $32.26B | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $32.41B | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $32.38B | May 2, 2024 |
| FY2024 | Dec 31, 2023 | $32.36B | Feb 13, 2025 |
| FY2023 | Sep 30, 2023 | $32.53B | Nov 1, 2023 |
| FY2023 | Jun 30, 2023 | $32.49B | Aug 3, 2023 |
| FY2023 | Mar 31, 2023 | $32.47B | May 3, 2023 |
| FY2023 | Dec 31, 2022 | $34.17B | Aug 1, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.31B) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($469.24M) | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | ($427.11M) | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | ($399.09M) | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | ($431.16M) | May 2, 2024 |
| FY2024 | Dec 31, 2023 | ($422.18M) | Feb 13, 2025 |
| FY2023 | Sep 30, 2023 | ($305.09M) | Nov 1, 2023 |
| FY2023 | Jun 30, 2023 | ($378.87M) | Aug 3, 2023 |
| FY2023 | Mar 31, 2023 | ($471.44M) | May 3, 2023 |
| FY2023 | Dec 31, 2022 | ($475.21M) | Aug 1, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.04B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $8.04B | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $8.04B | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $8.04B | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $8.04B | May 2, 2024 |
| FY2025 | Dec 31, 2023 | $8.04B | Feb 13, 2026 |
| FY2023 | Sep 30, 2023 | $8.21B | Aug 1, 2024 |
| FY2023 | Jun 30, 2023 | $8.21B | Aug 3, 2023 |
| FY2023 | Mar 31, 2023 | $8.21B | May 3, 2023 |
| FY2025 | Dec 31, 2022 | $8.21B | Feb 13, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.57B) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($703.99M) | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | ($649.88M) | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | ($606.91M) | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | ($622.27M) | May 2, 2024 |
| FY2024 | Dec 31, 2023 | ($601.08M) | Feb 13, 2025 |
| FY2023 | Sep 30, 2023 | ($483.27M) | Nov 1, 2023 |
| FY2023 | Jun 30, 2023 | ($550.11M) | Aug 3, 2023 |
| FY2023 | Mar 31, 2023 | ($628.41M) | May 3, 2023 |
| FY2023 | Dec 31, 2022 | ($654.27M) | Aug 1, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $256.53M | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $250.00M | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $362.11M | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $284.45M | May 2, 2024 |
| FY2024 | Dec 31, 2023 | $302.06M | Feb 13, 2025 |
| FY2023 | Sep 30, 2023 | $268.38M | Nov 1, 2023 |
| FY2023 | Jun 30, 2023 | $219.13M | Aug 3, 2023 |
| FY2023 | Mar 31, 2023 | $220.45M | May 3, 2023 |
| FY2023 | Dec 31, 2022 | $305.48M | Aug 1, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.21B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $25.06B | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | $25.05B | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | $25.21B | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | $25.06B | May 2, 2024 |
| FY2024 | Dec 31, 2023 | $25.07B | Feb 13, 2025 |
| FY2023 | Sep 30, 2023 | $25.12B | Nov 1, 2023 |
| FY2023 | Jun 30, 2023 | $25.12B | Aug 3, 2023 |
| FY2023 | Mar 31, 2023 | $25.00B | May 3, 2023 |
| FY2023 | Dec 31, 2022 | $26.59B | Aug 1, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | 0 | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | 0 | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | 0 | May 2, 2024 |
| FY2025 | Dec 31, 2023 | 0 | Feb 13, 2026 |
| FY2024 | Sep 30, 2023 | 0 | Nov 5, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Aug 1, 2024 |
| FY2024 | Mar 31, 2023 | 0 | May 2, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Feb 13, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 13, 2026 |
| FY2024 | Sep 30, 2024 | 0 | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | 0 | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | 0 | May 2, 2024 |
| FY2025 | Dec 31, 2023 | 0 | Feb 13, 2026 |
| FY2024 | Sep 30, 2023 | 0 | Nov 5, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Aug 1, 2024 |
| FY2024 | Mar 31, 2023 | 0 | May 2, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Feb 13, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | 276.97M | Nov 5, 2024 |
| FY2024 | Jun 30, 2024 | 276.36M | Aug 1, 2024 |
| FY2024 | Mar 31, 2024 | 275.74M | May 2, 2024 |
| FY2021 | Sep 30, 2021 | 454.65M | Nov 5, 2021 |
| FY2021 | Jun 30, 2021 | 457.08M | Jul 28, 2021 |
| FY2021 | Mar 31, 2021 | 461.98M | Apr 28, 2021 |
| FY2020 | Dec 31, 2020 | 476.47M | Feb 12, 2021 |
| FY2020 | Sep 30, 2020 | 563.15M | Oct 30, 2020 |
| FY2020 | Jun 30, 2020 | 579.79M | Jul 31, 2020 |
| FY2020 | Mar 31, 2020 | 602.99M | May 1, 2020 |